OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism

2016 ◽  
Vol 140 ◽  
pp. S172-S173 ◽  
Author(s):  
A. Young ◽  
J. Phillips ◽  
H. Hancocks ◽  
C. Hill ◽  
N. Joshi ◽  
...  
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Anticoagulation Therapy ◽  
Risk Of Recurrence ◽  
Patients At Risk

SELECT-D: Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS9661-TPS9661 ◽  
Author(s):  
Annie Young ◽  
Janet Dunn ◽  
Oliver Chapman ◽  
Joanne Grumett ◽  
Andrea Marshall ◽  
...  
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Anticoagulation Therapy ◽  
Risk Of Recurrence ◽  
Patients At Risk

Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS9642-TPS9642
Author(s):  
Annie Young ◽  
Jenny Phillips ◽  
Helen Hancocks ◽  
Andrea Marshall ◽  
Joanne Grumett ◽  
...  
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Anticoagulation Therapy ◽  
Risk Of Recurrence ◽  
Patients At Risk

Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study

2020 ◽  
Vol 191 ◽  
pp. S31-S36
Author(s):  
Anton Ilich ◽  
Vaibhav Kumar ◽  
Michael Henderson ◽  
Ranjeeta Mallick ◽  
Philip Wells ◽  
...  
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Patients At Risk

scholarly journals Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

2009 ◽  
Vol 5 (4) ◽  
pp. 159-164 ◽  
Author(s):  
Alpesh N. Amin ◽  
Jay Lin ◽  
Guiping Yang ◽  
Stephen Stemkowski
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Economic Outcomes ◽  
Thromboembolism Prophylaxis ◽  
Venous Thromboembolism Prophylaxis ◽  
Patients At Risk

Prophylaxis is often underused and inappropriately prescribed. This study compares the efficacy and cost of appropriate and partial prophylaxis in cancer patients at risk for VTE.

scholarly journals Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

2010 ◽  
Vol 12 (4) ◽  
Author(s):  
John MS Bartlett ◽  
Jeremy Thomas ◽  
Douglas T Ross ◽  
Robert S Seitz ◽  
Brian Z Ring ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Breast Cancer Patients ◽  
Risk Of Recurrence ◽  
Patients At Risk
Sign in / Sign up

Export Citation Format

Share Document